Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$680K
Filings
44
Firms Hired
2
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus; Issues pertaining to the FDA review of therapies to treat pediatric IBD.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5509
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus; Issues pertaining to the FDA review of therapies to treat pediatric IBD.
Client expense: — · Firm income: $30,000
Matched citations: S.2903
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: HR 5509
Medical Foods and Formulas Access Act of 2025
2026 · third_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: HR 5684
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: HR 6423
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: S 2903
Medical Foods and Formulas Access Act of 2025
2026 · third_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: S 3304
Pharmacy Benefit Manager Transparency Act of 2025
2026 · third_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: S 526
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies CMS - Medicaid work requirements FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP OMB - Proposed rule on Federal grantmaking
Client expense: $40,000 · Firm income: —
Matched citations: S 864
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5509
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus.
Client expense: — · Firm income: $20,000
Matched citations: S.2903
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: HR 5509
Medical Foods and Formulas Access Act of 2025
2026 · second_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: HR 5684
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: HR 6423
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: S 2903
Medical Foods and Formulas Access Act of 2025
2026 · second_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: S 3304
Pharmacy Benefit Manager Transparency Act of 2025
2026 · second_quarter · Firm: CROHN'S & COLITIS FOUNDATION
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: S 526
FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: S 864
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5509
FY 2026 Funding for medical research at the NIH and CDC FY 2026 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: HR 5509
FY 2026 Funding for medical research at the NIH and CDC FY 2026 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP
Client expense: $40,000 · Firm income: —
Matched citations: S 2903
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: CROHN'S & COLITIS FOUNDATION
H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies Reauthorization of ACA tax subsidies.
Client expense: $40,000 · Firm income: —
Matched citations: H.R.1
H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies Reauthorization of ACA tax subsidies.
Client expense: $40,000 · Firm income: —
Matched citations: HR 5509
H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies Reauthorization of ACA tax subsidies.
Client expense: $40,000 · Firm income: —
Matched citations: S 2903
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5509
Source: Senate LDA